Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2019

Open Access 01-12-2019 | Stroke | Research article

Interatrial block in prediction of all-cause mortality after first-ever ischemic stroke

Authors: M. A. Baturova, A. Lindgren, Y. V. Shubik, J. Carlson, P. G. Platonov

Published in: BMC Cardiovascular Disorders | Issue 1/2019

Login to get access

Abstract

Background

Interatrial block (IAB) is an ECG indicator of atrial fibrosis related to atrial remodeling and thrombus formation thus leading to embolic stroke and increasing mortality. We aimed to assess weather IAB predicted all-cause mortality during 10 years after ischemic stroke.

Methods

The study sample comprised 235 patients (median age 74 (interquartile range 25–75% 65–81) years, 95 female) included in the Lund Stroke Register in 2001–2002, who had sinus rhythm ECGs at stroke admission. IAB was defined as a P-wave duration ≥120 ms without = partial IAB (n = 56) or with = advanced IAB (n = 41) biphasic morphology (±) in the inferior ECG leads. All-cause mortality was assessed via linkage with the Swedish Causes of Death Register.

Results

During follow-up 126 patients died (54%). Advanced IAB, but not partial, was associated with all-cause mortality in univariate Cox regression analysis (hazard ratio (HR) 1.98, 95% CI 1.27–3.09, p = 0.003). After adjustment for age, gender, severity of stroke measured by NIHSS scale and smoking status in patients without additional comorbidities advanced IAB independently predicted all-cause mortality (HR 7.89, 95% CI 2.01–30.98, p = 0.003), while in patients with comorbidities it did not (HR 1.01 95% CI 0.59–1.72, p = 0.966).

Conclusion

Advanced IAB predicted all-cause mortality after ischemic stroke, but mostly in patients without additional cardiovascular comorbidities.
Literature
1.
go back to reference Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V, Rivera I, Iturralde P. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J. 1988;9(10):1112–8.PubMedCrossRef Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V, Rivera I, Iturralde P. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J. 1988;9(10):1112–8.PubMedCrossRef
2.
go back to reference Bayes de Luna A, Platonov P, Cosio FG, Cygankiewicz I, Pastore C, Baranowski R, Bayes-Genis A, Guindo J, Vinolas X, Garcia-Niebla J, et al. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol. 2012;45(5):445–51.PubMedCrossRef Bayes de Luna A, Platonov P, Cosio FG, Cygankiewicz I, Pastore C, Baranowski R, Bayes-Genis A, Guindo J, Vinolas X, Garcia-Niebla J, et al. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol. 2012;45(5):445–51.PubMedCrossRef
3.
go back to reference O'Neal WT, Zhang ZM, Loehr LR, Chen LY, Alonso A, Soliman EZ. Electrocardiographic advanced interatrial block and atrial fibrillation risk in the general population. Am J Cardiol. 2016;117(11):1755–9.PubMedPubMedCentralCrossRef O'Neal WT, Zhang ZM, Loehr LR, Chen LY, Alonso A, Soliman EZ. Electrocardiographic advanced interatrial block and atrial fibrillation risk in the general population. Am J Cardiol. 2016;117(11):1755–9.PubMedPubMedCentralCrossRef
4.
go back to reference Bernal E, Bayes-Genis A, Ariza-Sole A, Formiga F, Vidan MT, Escobar-Robledo LA, Aboal J, Alcoberro L, Guerrero C, Ariza-Segovia I, et al. Interatrial block, frailty and prognosis in elderly patients with myocardial infarction. J Electrocardiol. 2018;51(1):1–7.PubMedCrossRef Bernal E, Bayes-Genis A, Ariza-Sole A, Formiga F, Vidan MT, Escobar-Robledo LA, Aboal J, Alcoberro L, Guerrero C, Ariza-Segovia I, et al. Interatrial block, frailty and prognosis in elderly patients with myocardial infarction. J Electrocardiol. 2018;51(1):1–7.PubMedCrossRef
5.
go back to reference Magnani JW, Gorodeski EZ, Johnson VM, Sullivan LM, Hamburg NM, Benjamin EJ, Ellinor PT. P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and nutrition examination survey. Heart Rhythm. 2011;8(1):93–100.PubMedCrossRef Magnani JW, Gorodeski EZ, Johnson VM, Sullivan LM, Hamburg NM, Benjamin EJ, Ellinor PT. P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and nutrition examination survey. Heart Rhythm. 2011;8(1):93–100.PubMedCrossRef
6.
go back to reference O'Neal WT, Kamel H, Zhang ZM, Chen LY, Alonso A, Soliman EZ. Advanced interatrial block and ischemic stroke: the atherosclerosis risk in communities study. Neurology. 2016;87(4):352–6.PubMedPubMedCentralCrossRef O'Neal WT, Kamel H, Zhang ZM, Chen LY, Alonso A, Soliman EZ. Advanced interatrial block and ischemic stroke: the atherosclerosis risk in communities study. Neurology. 2016;87(4):352–6.PubMedPubMedCentralCrossRef
7.
go back to reference Baturova MA, Lindgren A, Shubik YV, Olsson SB, Platonov PG. Documentation of atrial fibrillation prior to first-ever ischemic stroke. Acta Neurol Scand. 2014;129(6):412–9.PubMedCrossRef Baturova MA, Lindgren A, Shubik YV, Olsson SB, Platonov PG. Documentation of atrial fibrillation prior to first-ever ischemic stroke. Acta Neurol Scand. 2014;129(6):412–9.PubMedCrossRef
8.
go back to reference Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke. 1999;30(8):1534–7.PubMedCrossRef Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke. 1999;30(8):1534–7.PubMedCrossRef
9.
go back to reference Macfarlane PW, Devine B, Clark E. The University of Glasgow (Uni-G) ECG analysis program. Comput Cardiol. 2005;32:451–4. Macfarlane PW, Devine B, Clark E. The University of Glasgow (Uni-G) ECG analysis program. Comput Cardiol. 2005;32:451–4.
10.
go back to reference Baturova MA, Lindgren A, Carlson J, Shubik YV, Bertil Olsson S, Platonov PG. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke. Int J Cardiol. 2017;232:134–9.PubMedCrossRef Baturova MA, Lindgren A, Carlson J, Shubik YV, Bertil Olsson S, Platonov PG. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke. Int J Cardiol. 2017;232:134–9.PubMedCrossRef
11.
go back to reference Henriksson KM, Farahmand B, Johansson S, Asberg S, Terent A, Edvardsson N. Survival after stroke--the impact of CHADS2 score and atrial fibrillation. Int J Cardiol. 2010;141(1):18–23.PubMedCrossRef Henriksson KM, Farahmand B, Johansson S, Asberg S, Terent A, Edvardsson N. Survival after stroke--the impact of CHADS2 score and atrial fibrillation. Int J Cardiol. 2010;141(1):18–23.PubMedCrossRef
12.
go back to reference Martinez-Selles M, Masso-van Roessel A, Alvarez-Garcia J, Garcia de la Villa B, Cruz-Jentoft AJ, Vidan MT, Lopez Diaz J, Felix Redondo FJ, Duran Guerrero JM, Bayes-Genis A, et al. Interatrial block and atrial arrhythmias in centenarians: prevalence, associations, and clinical implications. Heart Rhythm. 2016;13(3):645–51.PubMedCrossRef Martinez-Selles M, Masso-van Roessel A, Alvarez-Garcia J, Garcia de la Villa B, Cruz-Jentoft AJ, Vidan MT, Lopez Diaz J, Felix Redondo FJ, Duran Guerrero JM, Bayes-Genis A, et al. Interatrial block and atrial arrhythmias in centenarians: prevalence, associations, and clinical implications. Heart Rhythm. 2016;13(3):645–51.PubMedCrossRef
13.
go back to reference Gramley F, Lorenzen J, Knackstedt C, Rana OR, Saygili E, Frechen D, Stanzel S, Pezzella F, Koellensperger E, Weiss C, et al. Age-related atrial fibrosis. Age (Dordr). 2009;31(1):27–38.CrossRef Gramley F, Lorenzen J, Knackstedt C, Rana OR, Saygili E, Frechen D, Stanzel S, Pezzella F, Koellensperger E, Weiss C, et al. Age-related atrial fibrosis. Age (Dordr). 2009;31(1):27–38.CrossRef
14.
go back to reference Daccarett M, Badger TJ, Akoum N, Burgon NS, Mahnkopf C, Vergara G, Kholmovski E, McGann CJ, Parker D, Brachmann J, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–8.PubMedPubMedCentralCrossRef Daccarett M, Badger TJ, Akoum N, Burgon NS, Mahnkopf C, Vergara G, Kholmovski E, McGann CJ, Parker D, Brachmann J, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–8.PubMedPubMedCentralCrossRef
15.
go back to reference Holmqvist F, Platonov PG, McNitt S, Polonsky S, Carlson J, Zareba W, Moss AJ. Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients. Ann Noninvasive Electrocardiol. 2010;15(1):63–72.PubMedCrossRef Holmqvist F, Platonov PG, McNitt S, Polonsky S, Carlson J, Zareba W, Moss AJ. Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients. Ann Noninvasive Electrocardiol. 2010;15(1):63–72.PubMedCrossRef
16.
go back to reference Klesen A, Jakob D, Emig R, Kohl P, Ravens U, Peyronnet R. Cardiac fibroblasts : active players in (atrial) electrophysiology? Herzschrittmacherther Elektrophysiol. 2018;29(1):62–9.PubMedCrossRef Klesen A, Jakob D, Emig R, Kohl P, Ravens U, Peyronnet R. Cardiac fibroblasts : active players in (atrial) electrophysiology? Herzschrittmacherther Elektrophysiol. 2018;29(1):62–9.PubMedCrossRef
17.
go back to reference Gibson CM, Hankey GJ, Nafee T, Welsh RC. Beyond stroke prevention in atrial fibrillation: exploring further unmet needs with rivaroxaban. Thromb Haemost. 2018;118(S 01):S34–s44.PubMedCrossRef Gibson CM, Hankey GJ, Nafee T, Welsh RC. Beyond stroke prevention in atrial fibrillation: exploring further unmet needs with rivaroxaban. Thromb Haemost. 2018;118(S 01):S34–s44.PubMedCrossRef
18.
go back to reference Bayes de Luna A, Baranchuk A, Martinez-Selles M, Platonov PG. Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift? Ann Noninvasive Electrocardiol. 2017;22(1):e12417.CrossRef Bayes de Luna A, Baranchuk A, Martinez-Selles M, Platonov PG. Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift? Ann Noninvasive Electrocardiol. 2017;22(1):e12417.CrossRef
19.
go back to reference Bayes de Luna A, Martinez-Selles M, Bayes-Genis A, Elosua R, Baranchuk A. Surface ECG interatrial block-guided treatment for stroke prevention: rationale for an attractive hypothesis. BMC Cardiovasc Disord. 2017;17(1):211.PubMedPubMedCentralCrossRef Bayes de Luna A, Martinez-Selles M, Bayes-Genis A, Elosua R, Baranchuk A. Surface ECG interatrial block-guided treatment for stroke prevention: rationale for an attractive hypothesis. BMC Cardiovasc Disord. 2017;17(1):211.PubMedPubMedCentralCrossRef
20.
go back to reference Guzik A, Bushnell C. Stroke epidemiology and risk factor management. Continuum. 2017;23(1, Cerebrovascular Disease):15–39.PubMed Guzik A, Bushnell C. Stroke epidemiology and risk factor management. Continuum. 2017;23(1, Cerebrovascular Disease):15–39.PubMed
Metadata
Title
Interatrial block in prediction of all-cause mortality after first-ever ischemic stroke
Authors
M. A. Baturova
A. Lindgren
Y. V. Shubik
J. Carlson
P. G. Platonov
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2019
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-019-1015-5

Other articles of this Issue 1/2019

BMC Cardiovascular Disorders 1/2019 Go to the issue